Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 0.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 0.76 | 2.12 |
NAV | ₹23.11 | ₹13.93 |
Fund Started | 02 Mar 2019 | 21 Aug 2023 |
Fund Size | ₹212.14 Cr | ₹1182.22 Cr |
Exit Load | Exit load of 0.5% if redeemed within 15 days. | Exit load of 1%, if redeemed within 3 months |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 8.35% | 19.61% |
3 Year | 12.87% | - |
5 Year | 17.48% | - |
1 Year
3 Year
5 Year
Equity | 100.05% | 98.72% |
Cash | -0.05% | 1.28% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 7.53% |
Nestle India Ltd. | 7.30% |
Hindustan Unilever Ltd. | 7.25% |
Britannia Industries Ltd. | 7.02% |
Tata Consultancy Services Ltd. | 6.09% |
Apollo Hospitals Enterprise Ltd. | 6.02% |
Dr. Reddy's Laboratories Ltd. | 5.54% |
Tata Consumer Products Ltd. | 4.57% |
Cipla Ltd. | 3.70% |
ITC Ltd. | 2.54% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 6.97% |
Reliance Industries Ltd. | 4.67% |
State Bank of India | 4.10% |
Infosys Ltd. | 3.44% |
ITC Ltd. | 3.27% |
ICICI Bank Ltd. | 2.44% |
Indus Towers Ltd. | 2.33% |
Hindustan Unilever Ltd. | 2.28% |
Indusind Bank Ltd. | 2.15% |
Divi's Laboratories Ltd. | 2.09% |
Name | Raviprakash Sharma | Renjith Sivaram Radhakrishnan |
Start Date | 22 Aug 2011 | 03 Jul 2023 |
Name
Start Date
Description | The scheme seeks to provide long term capital appreciation by investing in a diversified basket of companies in Nifty 50 Index while aiming for minimizing the portfolio volatility. | The Scheme seek to generate long term capital appreciation by investing predominantly in equity and equity related securities with a focus on identifying and investing in business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy. |
Launch Date | 02 Mar 2019 | 21 Aug 2023 |
Description
Launch Date